Communications Biology (May 2022)

Lymphocyte activation gene-3-associated protein networks are associated with HDL-cholesterol and mortality in the Trans-omics for Precision Medicine program

  • Ani Manichaikul,
  • Honghuang Lin,
  • Chansuk Kang,
  • Chaojie Yang,
  • Stephen S. Rich,
  • Kent D. Taylor,
  • Xiuqing Guo,
  • Jerome I. Rotter,
  • W. Craig Johnson,
  • Elaine Cornell,
  • Russell P. Tracy,
  • J. Peter Durda,
  • Yongmei Liu,
  • Ramachandran S. Vasan,
  • L. Adrienne Cupples,
  • Robert E. Gerszten,
  • Clary B. Clish,
  • Deepti Jain,
  • Matthew P. Conomos,
  • Thomas Blackwell,
  • George J. Papanicolaou,
  • Annabelle Rodriguez

DOI
https://doi.org/10.1038/s42003-022-03304-0
Journal volume & issue
Vol. 5, no. 1
pp. 1 – 11

Abstract

Read online

Rodriguez et al. use whole genome sequencing and plasma proteomics from the Multi-Ethnic Study of Atherosclerosis (MESA) and the Framingham Heart Study (FHS) cohorts of the Trans-Omics for Precision Medicine program and perform in situ Hi-C chromatin capture in cell lines isolated from four MESA participants. They demonstrate that lymphocyte activation gene-3 protein networks are associated with HDL-cholesterol and mortality, which could guide the development of precision medicine.